Skip to main content
. Author manuscript; available in PMC: 2008 Dec 1.
Published in final edited form as: J Dermatol Sci. 2007 Aug 24;48(3):177–188. doi: 10.1016/j.jdermsci.2007.07.002

Figure 2.

Figure 2

Detection of LM-332 using immunofluorescence of whole mount wounds. Wounds treated with soluble biotinylated LM-332 and saline control at 1 and 24 hours. Arrowheads indicate wound margin. In soluble biotinylated LM-332 treated wounds, bright orange staining (fluorescent emission of streptavidin-Cy5) can be seen in the wound bed at both 1 and 24 hours after application, while immunofluorescence is absent in control wounds.